PERBANDINGAN LAMA RAWAT INAP PADA PASIEN GAGAL JANTUNG DENGAN TERAPI SPIRONOLAKTON DAN FUROSEMIDE DI RSUD DR. SOEKARDJO TASIKMALAYA

Joel Owenardo Maruli Tua, . (2023) PERBANDINGAN LAMA RAWAT INAP PADA PASIEN GAGAL JANTUNG DENGAN TERAPI SPIRONOLAKTON DAN FUROSEMIDE DI RSUD DR. SOEKARDJO TASIKMALAYA. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.

[img] Text
ABSTRAK.pdf

Download (139kB)
[img] Text
AWAL.pdf

Download (981kB)
[img] Text
BAB 1.pdf

Download (92kB)
[img] Text
BAB 2.pdf
Restricted to Repository UPNVJ Only

Download (595kB)
[img] Text
BAB 3.pdf
Restricted to Repository UPNVJ Only

Download (230kB)
[img] Text
BAB 4.pdf
Restricted to Repository UPNVJ Only

Download (248kB)
[img] Text
BAB 5.pdf

Download (138kB)
[img] Text
DAFTAR PUSTAKA.pdf

Download (168kB)
[img] Text
RIWAYAT HIDUP.pdf
Restricted to Repository UPNVJ Only

Download (110kB)
[img] Text
LAMPIRAN.pdf
Restricted to Repository UPNVJ Only

Download (2MB)
[img] Text
HASIL PLAGIARISME.pdf
Restricted to Repository staff only

Download (542kB)
[img] Text
ARTIKEL KI.pdf
Restricted to Repository staff only

Download (274kB)

Abstract

Cardiovascular disease is the highest non-communicable disease in the world every year, including heart failure (HF). Tasikmalaya City government’s data shows that HF is still the fourth highest inpatient disease at Dr. Soekardjo Tasikmalaya Regional General Hospital in 2020, with a total of 458 cases. Administration of spironolactone and furosemide are the two most frequently administered therapies for hospitalized HF patients with symptoms of congestion. This study aims to compare the length of stay of HF patients with spironolactone and furosemide therapy at Dr. Soekardjo Tasikmalaya Regional General Hospital. This is a descriptive-analytic observational study using a cohort-retrospective approach to 60 heart failure patients at Dr. Soekardjo Tasikmalaya Regional General Hospital from 2020-2021. The sampling technique used was the consecutive sampling method. Samples were divided into two groups, which consisted of 30 patients on spironolactone therapy and 30 patients on furosemide therapy. Using an unpaired t-test with the SPSS version 24.0 computer program, the results showed that the average length of stay of HF patients treated with spironolactone was 5,167 (±1,262) days. In contrast, the average length of stay of HF patients treated with furosemide was 5,9 (±1,626) days. A comparison of the average of the two groups showed a significant difference with a value of p=0.036. In conclusion, HF patients treated with spironolactone likely had a shorter average length of stay than HF patients treated with furosemide.

Item Type: Thesis (Skripsi)
Additional Information: [No.Panggil: 1910211064] [Pembimbing 1: Erna Harfiani] [Pembimbing 2: Yanto Sandy Tjang] [Penguji: Marlina Dewiastuti]
Uncontrolled Keywords: Furosemide, heart failure, length of stay, spironolactone
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
R Medicine > RZ Other systems of medicine
Divisions: Fakultas Kedokteran > Program Studi Kedokteran (S1)
Depositing User: Joel Owenardo Maruli Tua
Date Deposited: 02 Mar 2023 04:00
Last Modified: 02 Mar 2023 04:00
URI: http://repository.upnvj.ac.id/id/eprint/22226

Actions (login required)

View Item View Item